Delivery Order SPE2DB20D7059-SPE2DB24FQJP3

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,902.81, is for the supply of 4566665432 ! PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product, with a potential value of $9,405.37 and a completion date of February 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,682.45 contract is for the supply of 4560957331 ! PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a type of injectable medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order award under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The single-award IDC, valued at up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML. The contract has a ceiling value of $3,425.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Phytonadione 1 mg/0.5 mL syrup. The contract has a fixed-price, firm-fixed-price pricing structure and a period of performance through March 27, 2024. The contract ceiling value is $5,757.95. This order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,652.04, is for the supply of 4565936267 - PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. The delivery order has a completion date of September 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is valued at $5,659.98 and is for the delivery of the pharmaceutical product phytonadione 1 mg/0.5 mL syringe, 0.5 mL. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the provision of 4564572279 - Phytonadione 5 mg Tablet 100s. The contract has a Ceiling Value of $8,314.90 and a Period of Performance through May 13, 2024. It is a Firm Fixed Price contract awarded without a Set-Aside designation. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of phytonadione 1 mg/0.5 ml syrup, a medical product, with a ceiling value of $6,013.36 and a completion date of February 5, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQJP3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. The contract has a ceiling value of $2,144.50 and a period of performance through July 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 10:19 AM